Hirofumi Hamanaka

Hirofumi Hamanaka has experience in various leadership roles in the pharmaceutical and healthcare industry. Currently serving as Vice President of Health Care at Impute Inc., Hirofumi also holds the title of Representative of Japan office at Shanghai LISOR Pharmaceutical Technology Co., a subsidiary of China Sino Pharma Group. Additionally, Hirofumi is the CEO of Veras Research Japan Ltd. / ACA (Asia CRO Alliance) Organizer. With a background as the Japan Representative at Chiltern Japan and Senior Vice President at Japan Domestic CRO, Hamanaka has a wealth of experience in the industry.